Loading
Every trade that managers of Sundrug Co.,Ltd. disclose to EDINET (Japan FSA) is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 4 filings came from 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
With 4 filings in twelve months, the company is more active than the median of 3 filings across the 3,423 companies we follow on the same exchange.
No insider has bought Sundrug Co.,Ltd. shares on the open market in the past twelve months. The median gap between a trade and its publication by EDINET (Japan FSA) is 7 days. That lag is the time during which only the insider knows about the trade.
Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.
Analysts rate Sundrug Co.,Ltd. Buy (bullish), based on 7 analysts. Average price target: JP¥4,674.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
7 of 7 declarations
Sandrug Co., Ltd. is a Japanese company specializing in the retail of pharmaceutical and health products. It primarily operates in the over-the-counter drug and beauty product market.